Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies.

about

Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups.Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab

P2860

Q48170767-5E24DAB9-B516-4BEF-967D-5DC4A7AB27EE Q58720009-04C40197-7FA0-4817-B5B0-B530AA4E0220

P2860

Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies.

Item

http://www.wikidata.org/entity/Q47937410

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Efficacy of guselkumab in subp ...... VOYAGE 1 and VOYAGE 2 studies.

@en

Efficacy of guselkumab in subp ...... VOYAGE 1 and VOYAGE 2 studies.

@nl

type

Item

label

Efficacy of guselkumab in subp ...... VOYAGE 1 and VOYAGE 2 studies.

@en

Efficacy of guselkumab in subp ...... VOYAGE 1 and VOYAGE 2 studies.

@nl

prefLabel

Efficacy of guselkumab in subp ...... VOYAGE 1 and VOYAGE 2 studies.

@en

Efficacy of guselkumab in subp ...... VOYAGE 1 and VOYAGE 2 studies.

@nl

P1476

Efficacy of guselkumab in subp ...... VOYAGE 1 and VOYAGE 2 studies.

@en

P2093

A Blauvelt

http://www.w3.org/2001/XMLSchema#string

B Randazzo

http://www.w3.org/2001/XMLSchema#string

C E M Griffiths

http://www.w3.org/2001/XMLSchema#string

K B Gordon

http://www.w3.org/2001/XMLSchema#string

M Song

http://www.w3.org/2001/XMLSchema#string

P Foley

http://www.w3.org/2001/XMLSchema#string

Y K Shen

http://www.w3.org/2001/XMLSchema#string

Y Wasfi

http://www.w3.org/2001/XMLSchema#string

Y You

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.

Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials.

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population.

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active compa

Barriers to guideline-compliant psoriasis care: analyses and concepts.

P304

132-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJD.16008

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28940259

http://www.w3.org/2001/XMLSchema#string

Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies.

about

P2860

P2860

Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698